Chemours
(NYSE:CC)
$25.70
-3.18[-11.01%]
At close: Mar 28
$25.70
0[0.00%]
After Hours: 4:04PM EDT
Q4 2023 Earnings were released on Wed Mar 27th, after the market close
Consensus Rating1
Neutral
Highest Price Target1
$47.00
Lowest Price Target1
$19.00
Consensus Price Target1
$27.53

Chemours Stock (NYSE:CC), Analyst Ratings, Price Targets, Predictions

The Chemours Co has a consensus price target of $27.53, established from looking at the 57 latest analyst ratings. The last 3 analyst ratings were released from UBS, BMO Capital, and BMO Capital on March 5, 2024, March 1, 2024, and February 29, 2024. With an average price target of $19.67 between UBS, BMO Capital, and BMO Capital, there's an implied -23.48% downside for The Chemours Co from these 3 analyst ratings.

Analyst Rating Summary1

Analyst Ratings
Oct 23
1
4
Nov 23
1
Dec 23
1
Feb
1
Mar
1
1
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

UBS
BMO Capital
RBC Capital
JP Morgan
Goldman Sachs

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Chemours

date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
03/05/2024CCBuy Now
Chemours
$25.70-18.29%UBS
Joshua Spector
$37 → $21DowngradeBuy → NeutralGet Alert
03/01/2024CCBuy Now
Chemours
$25.70-26.07%BMO Capital
John McNulty
$45 → $19DowngradeOutperform → UnderperformGet Alert
02/29/2024CCBuy Now
Chemours
$25.70-26.07%BMO Capital
John McNulty
$45 → $19DowngradeOutperform → UnderperformGet Alert
12/01/2023CCBuy Now
Chemours
$25.7055.64%RBC Capital
Arun Viswanathan
$28 → $40UpgradeSector Perform → OutperformGet Alert
11/07/2023CCBuy Now
Chemours
$25.701.17%JP Morgan
Jeffrey Zekauskas
$38 → $26MaintainsNeutralGet Alert
10/31/2023CCBuy Now
Chemours
$25.7016.73%Goldman Sachs
Duffy Fischer
$35 → $30MaintainsNeutralGet Alert
10/30/2023CCBuy Now
Chemours
$25.708.95%RBC Capital
Arun Viswanathan
$30 → $28MaintainsSector PerformGet Alert
10/30/2023CCBuy Now
Chemours
$25.7051.75%BMO Capital
John McNulty
$45 → $39MaintainsOutperformGet Alert
10/30/2023CCBuy Now
Chemours
$25.708.95%Morgan Stanley
Vincent Andrews
$33 → $28MaintainsEqual-WeightGet Alert
10/30/2023CCBuy Now
Chemours
$25.708.95%Barclays
Michael Leithead
$31 → $28MaintainsEqual-WeightGet Alert
10/04/2023CCBuy Now
Chemours
$25.7020.62%Barclays
Michael Leithead
$40 → $31MaintainsEqual-WeightGet Alert
08/02/2023CCBuy Now
Chemours
$25.70106.23%BMO Capital
John McNulty
$64 → $53MaintainsOutperformGet Alert
08/01/2023CCBuy Now
Chemours
$25.7028.4%Morgan Stanley
Vincent Andrews
$33 → $33ReiteratesEqual-Weight → Equal-WeightGet Alert
07/31/2023CCBuy Now
Chemours
$25.7055.64%RBC Capital
Arun Viswanathan
$37 → $40MaintainsSector PerformGet Alert
07/19/2023CCBuy Now
Chemours
$25.7028.4%Morgan Stanley
Vincent Andrews
$33 → $33ReiteratesEqual-Weight → Equal-WeightGet Alert
07/11/2023CCBuy Now
Chemours
$25.7055.64%Barclays
Michael Leithead
$38 → $40MaintainsEqual-WeightGet Alert
06/22/2023CCBuy Now
Chemours
$25.7043.97%B of A Securities
Matthew DeYoe
$41 → $37DowngradeBuy → NeutralGet Alert
06/13/2023CCBuy Now
Chemours
$25.7067.32%UBS
Joshua Spector
$41 → $43MaintainsBuyGet Alert
06/09/2023CCBuy Now
Chemours
$25.7043.97%RBC Capital
Arun Viswanathan
$36 → $37MaintainsSector PerformGet Alert

FAQ

Q

What is the target price for Chemours (CC)?

A

The latest price target for Chemours (NYSE: CC) was reported by UBS on March 5, 2024. The analyst firm set a price target for $21.00 expecting CC to fall to within 12 months (a possible -18.29% downside). 24 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Chemours (CC)?

A

The latest analyst rating for Chemours (NYSE: CC) was provided by UBS, and Chemours downgraded their neutral rating.

Q

When was the last upgrade for Chemours (CC)?

A

The last upgrade for The Chemours Co happened on December 1, 2023 when RBC Capital raised their price target to $40. RBC Capital previously had a sector perform for The Chemours Co.

Q

When was the last downgrade for Chemours (CC)?

A

The last downgrade for The Chemours Co happened on March 5, 2024 when UBS changed their price target from $37 to $21 for The Chemours Co.

Q

When is the next analyst rating going to be posted or updated for Chemours (CC)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Chemours, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Chemours was filed on March 5, 2024 so you should expect the next rating to be made available sometime around March 5, 2025.

Q

Is the Analyst Rating Chemours (CC) correct?

A

While ratings are subjective and will change, the latest Chemours (CC) rating was a downgraded with a price target of $37.00 to $21.00. The current price Chemours (CC) is trading at is $25.70, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch